Ear Infection Treatment Market Growth, Size | Forecast 2031

Report Description

The global ear infection treatment market size was USD 11.20 Bn in 2022 and is likely to reach USD 17.60 Bn by 2031, expanding at a CAGR of 5.15% during 2023–2031. The market growth is attributed to the rising prevalence of ear infections and the growing demand for ear infection-related surgeries.

Increasing prevalence of ear infections among adults and children, owing to an unhygienic lifestyle and lack of awareness related to maintaining ear health, is driving the demand for ear infection treatment across worldwide regions. In addition, the demand for safe and effective ear infection treatments is leading to the development of innovative treatment and ENT device solutions, which are convenient and minimally invasive.

Get Free Sample Report

• According to the estimations by World Health Organization (WHO), unexamined hearing loss costs the world economy USD 980 billion each year, due to health sector costs (excluding the cost of hearing devices), educational support costs, productivity loss, and societal costs. Hearing loss is commonly caused by chronic middle ear infections, congenital or early onset childhood hearing loss, age-related hearing loss, noise-induced hearing loss, and ototoxic drugs that affect the inner ear.

The treatment for an ear infection is dependent on the type and severity of the infection. Ear infections can be treated with conservation measures and medication. Some common approaches to treating ear infections include antibiotics, pain relief, ear drops, warm compresses, surgical intervention, and others.

Ear infections cause when a virus and bacteria infect the space behind a child’s eardrum. Ear pain may cause toddlers or infants to be fussy or irritable. Chronic infection persists for a prolonged period, typically more than six months, but acute infection develops quickly and lasts for a short period, typically less than six months.

The market report finds that the COVID-19 pandemic has significantly affected the ear infections treatment market. According to the National Institutes of Health, during the pandemic, the antibiotic prescription rate for respiratory/ear infections declined from 21% to 13%.

Patients were unable to visit the clinics to conduct their routine check-ups, due to the pandemic regulations. However, the market is likely to witness substantial growth, due to the increase in product launches for ear infection treatment and growing awareness about ear-related infections.

Ear Infection Treatment Market Dynamics

Get Free Sample Report

Major Drivers

Increasing prevalence of ear infections all over the world is expected to boost the market for ear infection treatments. Ear infections can result in hearing loss, due to inflammation and fluid buildup behind the ear drum.

• According to the WHO, about 2.5 billion individuals worldwide, are expected to have hearing loss, and around 700 million are likely to require hearing rehabilitation by 2050. The report further states that around 1 billion young adults are at risk of permanent, avoidable hearing loss, owing to unsafe listening practices such as listening to loud music over the earphone or speakers.

Increasing ear infection cases, due to climatic change, cold, cough, and cigarette smoke is expected to fuel the market. Cigarette smoke causes inflammation of the Eustachian tube, which results in ear infections. Smoking weakens the immune system and damages the tissues in the throat and nose, making them more vulnerable to infections, which can affect the ears as well.  High demand for safe and effective ear infection treatment, is expected to further fuel the growth of the market in the coming years.

Existing Restraints

The high cost of treatments is anticipated to restrain the ear infection treatment market. Antibiotics, such as Amoxicillin, are prescribed for bacterial ear infections, which cost between USD 20 and USD 110 for a week of treatments.

• According to the American Academy of Otolaryngology-Head and Neck Surgery, ear tubes typically cost around USD 2000-5000 for people with insurance.

Increasing complications due to ear-related surgical procedures are expected to hamper the market. If the ear treatment does not work and the ear infection continues to spread, it causes severe complications such as hearing loss, meningitis, and brain abscess. For instance, labyrinthine fistula, accidental ossicular chain disruption, and Dural injury are the common possible complications related to ear surgery.

Emerging Opportunities

Increasing research and development (R&D) activities are expected to create lucrative opportunities for the market players. Major players are focusing on new product launches for ear infections. For instance,

• In March 2020, Sandoz, a division of the Novartis Group, launched Ciprofloxacin 0.3% + Dexamethasone 0.1% otic suspension 7.5mL ear drops, for the treatment of outer ear and middle ear canal bacterial infections.

Scope of Ear Infection Treatment Market Report

The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.

Ear Infection Treatment Market Segment Insights

Drug Type Segment Analysis

Based on drug type, the ear infection treatment market is divided into antibiotics, analgesics, corticosteroids, and others. The antibiotics segment is expected to expand at a significant pace during the projection period with their rising prescriptions by medical professionals.

Antibiotics are generally prescribed to help eliminate the bacterial ear infection. It is important to complete the full course of antibiotics as prescribed by the healthcare provider. Amoxicillin is one of the commonly prescribed antibiotics for ear infection treatment, especially in adults and children.

Get Free Sample Report

Infection Type Segment Analysis

On the basis of infection type, the market is segregated into inner ear infection, middle ear infection, and outer ear infection. The middle ear infection segment is projected to register a considerable CAGR during the forecast period. A middle ear infection, also known as otitis media, typically occurs when viruses and bacteria enter the middle ear through the eustachian tube. It causes inflammation in the middle ear, the space behind the eardrum.

• According to the National Institute of Health, acute otitis media can occur at any age. It is most commonly observed between the age of 6 to 24 months. Approximately 80% of children are likely to experience a case of otitis media The report further states that between 80% and 90% of all children are likely to have a middle ear infection with an effusion before they reach school age.

The inner ear infection segment is anticipated to hold a key share of the market in the coming years. An inner ear infection is also known as labyrinthitis or inner ear inflammation occurring in the inner ear, which affects hearing and balance. This infection can be caused by a cold, cough, or flu. There are two types of inner ear infections, namely labyrinthitis, and vestibular neuritis.

Infection Cause Segment Analysis

On the basis of infection cause, the market is bifurcated into viral infection and bacterial infection. The bacterial infection segment is anticipated to hold a key share of the market in the coming years due to the growing prevalence of bacterial infectious diseases. Streptococcus pneumoniae and Haemophilus influenzae, are the most common bacterial cause of acute infections. For instance,

• According to the National Institute of Health (NIH), the overall rate of Streptococcus pneumoniae infection in the US is 5.16 to 6.11 cases per 100,000 adults, it is 36.4 cases per 100,000 in individuals above 65 years of age group, and in infants, it is 34.5 per 100,000 counts.

End-user Segment Analysis

Based on end-user, the market is segmented into hospitals, clinics, and home care settings. The hospitals segment is expected to register a robust growth rate during the forecast period. In the healthcare industry, medical advances and improvements in medicine and technology are fueling the demand for healthcare services.

The growing awareness about ear infections is boosting the number of individuals seeking quality ear health solutions at hospitals. It is supported by growing disposable income and the expansion of healthcare facilities & treatments by hospitals worldwide.

Get Free Sample Report

Regional Outlook

In terms of region, the global ear infection treatment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to the high prevalence of ear infections, and the availability of quality healthcare treatments and resources. The region’s market is also supported by the increasing product launches for treating ear infections from the medical device manufacturing industry.

The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, owing to the increasing number of patients with ear infections. Increasing technological advancements and a rise in disposable income are likely to boost the market in the region. The affordability and awareness factors about ear infections are projected to significantly influence the market growth in the region.

Get Free Sample Report